Raphaël Blanc
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Raphaël Blanc has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Michel Piotin
Interventional Neuroradiology Department, Hôpital Fondation A. de Rothschild, Paris, France
14 shared publications - Gabriele Ciccio
Department of Interventional Neuroradiology (S.S., G.C.), Rothschild Foundation Hospital, Paris, France
5 shared publications Hocine Redjem
Interventionnal Neuroradiology, Rothschild Foundation, Paris, France
5 shared publications- Stanislas Smajda
Department of Interventional Neuroradiology, Rothschild Foundation Hospital, Paris, France (S. Smajda, S.A.S.).
5 shared publications - Bertrand Lapergue
Hôpital FOCH, Service de Neurologie et Unité de Neuro Vasculaire, Suresnes, France (B.L.).
4 shared publications Bruno Bartolini
Department of Interventional Neuroradiology, Fondation Rothschild Hospital, Paris, France
4 shared publications
Latest Publications
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract 157: Contact Aspiration Versus Stent Retriever for Large Vessel Occlusion in the Anterior Circulation Within Six Hours of Symptom Onset: Effect of Mothership Versus Drip and Ship Paradigms in the ASTER Trial
Purpose: The ASTER trial (contact Aspiration versus Stent Retriever for revascularization in patients presenting with acute ischemic stroke and a large vessel occlusion in the anterior circulation within six hours of symptom onset) did not show superiority of contact aspiration over stent retriever regarding successful revascularization (TICI 2B/3) result at the end of the procedure and clinical results at 3 months. Objective: To assess whether patient admission modes, directly to a comprehensive stroke center (CSC) versus to a primary stroke center (PSC), impacted the rate of patients with functional independence at 3 months and the rate of favorable angiographic outcome in the ASTER trial. Methods: Primary outcomes included degree of functional independence (modified Rankin scale ≤2) at 90 days, the change in National Institute of Health Stroke Scale (NIHSS) at 24 hours, all-cause mortality at 90 days, and procedure-related serious adverse events. Secondary outcome was the proportion of patients with successful revascularization defined as a modified Thrombolysis In Cerebral Infarction [mTICI] score of 2b or 3 at the end of procedure. Results: Among 381 patients who were randomized in the ASTER trial, 138 were directly admitted to a CSC (Mothership paradigm) and 243 were admitted first in a PSC (Drip-and-Ship paradigm). Aspiration as first strategy was performed in 50.7% of the patients in the Mothership paradigm group, versus 50.2% in the Drip-and-Ship. Onset to groin puncture time was 170 minutes (IQR, 142 to 207) in the Mothership group versus 262 minutes (IQR, 216 to 295) in the Drip-and-Ship group (pConclusions: The Mothership treatment paradigm did not result in better functional neurological outcome at 3 months compared to the Drip-and-Ship paradigm, whatever the first line treatment strategy.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract 157: Contact Aspiration Versus Stent Retriever for Large Vessel Occlusion in the Anterior Circulation Within Six Hours of Symptom Onset: Effect of Mothership Versus Drip and Ship Paradigms in the ASTER Trial
Purpose: The ASTER trial (contact Aspiration versus Stent Retriever for revascularization in patients presenting with acute ischemic stroke and a large vessel occlusion in the anterior circulation within six hours of symptom onset) did not show superiority of contact aspiration over stent retriever regarding successful revascularization (TICI 2B/3) result at the end of the procedure and clinical results at 3 months. Objective: To assess whether patient admission modes, directly to a comprehensive stroke center (CSC) versus to a primary stroke center (PSC), impacted the rate of patients with functional independence at 3 months and the rate of favorable angiographic outcome in the ASTER trial. Methods: Primary outcomes included degree of functional independence (modified Rankin scale ≤2) at 90 days, the change in National Institute of Health Stroke Scale (NIHSS) at 24 hours, all-cause mortality at 90 days, and procedure-related serious adverse events. Secondary outcome was the proportion of patients with successful revascularization defined as a modified Thrombolysis In Cerebral Infarction [mTICI] score of 2b or 3 at the end of procedure. Results: Among 381 patients who were randomized in the ASTER trial, 138 were directly admitted to a CSC (Mothership paradigm) and 243 were admitted first in a PSC (Drip-and-Ship paradigm). Aspiration as first strategy was performed in 50.7% of the patients in the Mothership paradigm group, versus 50.2% in the Drip-and-Ship. Onset to groin puncture time was 170 minutes (IQR, 142 to 207) in the Mothership group versus 262 minutes (IQR, 216 to 295) in the Drip-and-Ship group (pConclusions: The Mothership treatment paradigm did not result in better functional neurological outcome at 3 months compared to the Drip-and-Ship paradigm, whatever the first line treatment strategy.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WMP3: Unknown Onset Strokes With Anterior Circulation Occlusion Treated by Thrombectomy After DWI-FLAIR Mismatch Selection
Background and Purpose: Unknown-onset strokes (UOS) have often been considered seperately from known-onset strokes (KOS), since emergency recanalization treatments are based on a time-window. Improvement in imaging-based selection and the advent of endovascular thrombectomy may lead us to reconsider this practice. Methods: We performed a retrospective, multicenter, cohort study of consecutive UOS treated by thrombectomy between December 2012 and December 2016. We compared UOS with proximal anterior circulation occlusion discovered beyond 6 hours from “last seen normal” with KOS for whom thrombectomy was started within 6 hours from onset. Time intervals from first found abnormal were recorded and compared with time intervals of KOS. Results were adjusted for age, initial National Institutes of Health Stroke Scale score, site of occlusion, diffusion weighted imaging Alberta Stroke Program Early CT Score, intravenous thrombolysis and use of general anesthesia. Results: Among 1246 strokes with anterior circulation occlusion treated by thrombectomy, 277 were UOS, with a “last time seen well” beyond 6 hours and DWI-FLAIR mismatch, and 865 were KOS who underwent groin puncture within 6 hours. Favorable outcome was achieved less often in UOS than KOS patients (45.2% vs. 53.9%, p=0.022). After pre-specified adjustment, this difference was not significant (adusted relative risk=0.91; 95%CI, 0.80 to 1.04; p=0.17). No differences in secondary outcomes were found except a marginal difference for excellent outcome (adjusted relative risk=0.83; 95%CI, 0.69 to 1.00; p=0.052), Time intervals from “first found abnormal” were significantly longer in UOS. Conclusion: Endovascular treatment of unknown-onset strokes with anterior circulation occlusion and DWI-FLAIR mismatch appears to be as safe and efficient as endovascular treatment of known-onset strokes within 6 hours from onset. This pattern of imaging could be used for patient selection when time of onset is unknown.
- 22 January 2018
- Published by Wolters Kluwer Health in Stroke
- Vol. 49 (Suppl_1)
Abstract WMP3: Unknown Onset Strokes With Anterior Circulation Occlusion Treated by Thrombectomy After DWI-FLAIR Mismatch Selection
Background and Purpose: Unknown-onset strokes (UOS) have often been considered seperately from known-onset strokes (KOS), since emergency recanalization treatments are based on a time-window. Improvement in imaging-based selection and the advent of endovascular thrombectomy may lead us to reconsider this practice. Methods: We performed a retrospective, multicenter, cohort study of consecutive UOS treated by thrombectomy between December 2012 and December 2016. We compared UOS with proximal anterior circulation occlusion discovered beyond 6 hours from “last seen normal” with KOS for whom thrombectomy was started within 6 hours from onset. Time intervals from first found abnormal were recorded and compared with time intervals of KOS. Results were adjusted for age, initial National Institutes of Health Stroke Scale score, site of occlusion, diffusion weighted imaging Alberta Stroke Program Early CT Score, intravenous thrombolysis and use of general anesthesia. Results: Among 1246 strokes with anterior circulation occlusion treated by thrombectomy, 277 were UOS, with a “last time seen well” beyond 6 hours and DWI-FLAIR mismatch, and 865 were KOS who underwent groin puncture within 6 hours. Favorable outcome was achieved less often in UOS than KOS patients (45.2% vs. 53.9%, p=0.022). After pre-specified adjustment, this difference was not significant (adusted relative risk=0.91; 95%CI, 0.80 to 1.04; p=0.17). No differences in secondary outcomes were found except a marginal difference for excellent outcome (adjusted relative risk=0.83; 95%CI, 0.69 to 1.00; p=0.052), Time intervals from “first found abnormal” were significantly longer in UOS. Conclusion: Endovascular treatment of unknown-onset strokes with anterior circulation occlusion and DWI-FLAIR mismatch appears to be as safe and efficient as endovascular treatment of known-onset strokes within 6 hours from onset. This pattern of imaging could be used for patient selection when time of onset is unknown.
- 1 March 2016
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 43 (2) , 127
Expérience préliminaire avec le stent Neuroform Atlas dans le traitement des anévrismes intracrâniens
- 1 March 2016
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 43 (2) , 127
Expérience préliminaire avec le stent Neuroform Atlas dans le traitement des anévrismes intracrâniens
- 1 March 2016
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 43 (2) , 84
Traitement endovasculaire des AVC ischémiques par occlusion en tandem
- 1 March 2016
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 43 (2) , 84
Traitement endovasculaire des AVC ischémiques par occlusion en tandem
- 1 March 2016
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 43 (2) , 83
Impact de la recanalisation par thrombectomie chez des patients avec un score DWI-ASPECT≤6
- 1 March 2016
- Published by Elsevier in Journal Of Neuroradiology
- Vol. 43 (2) , 83
Impact de la recanalisation par thrombectomie chez des patients avec un score DWI-ASPECT≤6
- Open Access
- 3 October 2014
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 7 (11) , 841-847
Multimodal angiographic assessment of cerebral arteriovenous malformations: a pilot study
Purpose We describe our protocol of three-dimensional (3D) Roadmap intracranial navigation and image fusion for analysis of the angioarchitecture and endovascular treatment of brain arteriovenous malformations (AVMs). Methods We performed superselective catheterization of brain AVMs feeders under 3D-Roadmap navigation. Angiograms of each catheterized artery on two registered orthogonal views were transferred to the imaging workstations, and dedicated postprocessing imaging software allowed automated multiple overlays of the arterial supply of the AVM superselective acquisitions on the global angiogram in angiographic or 3D views and on coregistered MRI datasets. Results 11 untreated brain AVMs (4 with hemorrhagic presentation) were explored. The superselective acquisitions were performed under 3D-Roadmap navigation in 74 arteries, for a total of 79 targeted arteries. Imaging analysis was available at table side or postoperatively for discussion of the therapeutic strategy. No complications occurred during superselective catheterization. The accuracy of the coregistration of angiogram and MRI was submillimetric after automated mutual information coregistration, with manual re-registration by the physicians. Conclusions Superselective angiograms acquired under 3D-Roadmap navigation can be postprocessed with multiple overlays. The fluoroscopic navigation under 3D-Roadmapping and the coregistration of 3D rotational angiography, selective angiography, and 3D MR datasets appears reliable with millimeter accuracy, and could be implemented in the critical brain AVM embolization setting to allow refined analysis of AVM angioarchitecture.
- 3 October 2014
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 7 (11) , 841-847
Open AccessMultimodal angiographic assessment of cerebral arteriovenous malformations: a pilot study
Purpose We describe our protocol of three-dimensional (3D) Roadmap intracranial navigation and image fusion for analysis of the angioarchitecture and endovascular treatment of brain arteriovenous malformations (AVMs). Methods We performed superselective catheterization of brain AVMs feeders under 3D-Roadmap navigation. Angiograms of each catheterized artery on two registered orthogonal views were transferred to the imaging workstations, and dedicated postprocessing imaging software allowed automated multiple overlays of the arterial supply of the AVM superselective acquisitions on the global angiogram in angiographic or 3D views and on coregistered MRI datasets. Results 11 untreated brain AVMs (4 with hemorrhagic presentation) were explored. The superselective acquisitions were performed under 3D-Roadmap navigation in 74 arteries, for a total of 79 targeted arteries. Imaging analysis was available at table side or postoperatively for discussion of the therapeutic strategy. No complications occurred during superselective catheterization. The accuracy of the coregistration of angiogram and MRI was submillimetric after automated mutual information coregistration, with manual re-registration by the physicians. Conclusions Superselective angiograms acquired under 3D-Roadmap navigation can be postprocessed with multiple overlays. The fluoroscopic navigation under 3D-Roadmapping and the coregistration of 3D rotational angiography, selective angiography, and 3D MR datasets appears reliable with millimeter accuracy, and could be implemented in the critical brain AVM embolization setting to allow refined analysis of AVM angioarchitecture.
- Open Access
- 27 March 2014
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 35 (5) , 978-983
Hemorrhagic Complications after Endovascular Treatment of Cerebral Arteriovenous Malformations
BACKGROUND AND PURPOSE: Intracranial hemorrhage is the most severe complication of brain arteriovenous malformation treatment. We report our rate of hemorrhagic complications after endovascular treatment and analyze the clinical significance and potential mechanisms, with emphasis on cases of delayed hemorrhage after uneventful embolization. MATERIALS AND METHODS: During a 10-year period, 846 embolization procedures were performed in 408 patients with brain AVMs. Any cases of hemorrhagic complications were identified and divided into those related or unrelated to a periprocedural arterial tear (during catheter navigation or catheter retrieval). We analyzed the following variables: sex, age, hemorrhagic presentation, Spetzler-Martin grade, size of the AVM, number of embolized pedicles, microcatheter used, type and volume of liquid embolic agent injected, and the presence of a premature venous occlusion. Univariate and multivariate multiple regression analyses were performed to identify risk factors for hemorrhagic complications. RESULTS: A hemorrhagic complication occurred in 92 (11%) procedures. Forty-four (48%) complications were related to a periprocedural arterial perforation, and 48 (52%) were not. Hemorrhagic complications unrelated to an arterial perforation were located more commonly in the cerebral parenchyma, caused more neurologic deficits, and were associated with worse prognosis than those in the arterial perforation group. Only premature venous occlusion was identified as an independent predictor of hemorrhagic complication in the nonperforation group. Premature venous occlusion was significantly related to the ratio of Onyx volume to nidus diameter. CONCLUSIONS: Higher injected volume of embolic agent and deposition on the venous outflow before complete occlusion of the AVM may account for severe hemorrhagic complications.
- 27 March 2014
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 35 (5) , 978-983
Open AccessHemorrhagic Complications after Endovascular Treatment of Cerebral Arteriovenous Malformations
BACKGROUND AND PURPOSE: Intracranial hemorrhage is the most severe complication of brain arteriovenous malformation treatment. We report our rate of hemorrhagic complications after endovascular treatment and analyze the clinical significance and potential mechanisms, with emphasis on cases of delayed hemorrhage after uneventful embolization. MATERIALS AND METHODS: During a 10-year period, 846 embolization procedures were performed in 408 patients with brain AVMs. Any cases of hemorrhagic complications were identified and divided into those related or unrelated to a periprocedural arterial tear (during catheter navigation or catheter retrieval). We analyzed the following variables: sex, age, hemorrhagic presentation, Spetzler-Martin grade, size of the AVM, number of embolized pedicles, microcatheter used, type and volume of liquid embolic agent injected, and the presence of a premature venous occlusion. Univariate and multivariate multiple regression analyses were performed to identify risk factors for hemorrhagic complications. RESULTS: A hemorrhagic complication occurred in 92 (11%) procedures. Forty-four (48%) complications were related to a periprocedural arterial perforation, and 48 (52%) were not. Hemorrhagic complications unrelated to an arterial perforation were located more commonly in the cerebral parenchyma, caused more neurologic deficits, and were associated with worse prognosis than those in the arterial perforation group. Only premature venous occlusion was identified as an independent predictor of hemorrhagic complication in the nonperforation group. Premature venous occlusion was significantly related to the ratio of Onyx volume to nidus diameter. CONCLUSIONS: Higher injected volume of embolic agent and deposition on the venous outflow before complete occlusion of the AVM may account for severe hemorrhagic complications.
- 6 December 2012
- Published by Wiley in Acta Paediatrica
- Vol. 102 (2) , e50-e51
Acute ischaemic stroke due to carotid dissection in a boy with Down syndrome
- 6 December 2012
- Published by Wiley in Acta Paediatrica
- Vol. 102 (2) , e50-e51
Acute ischaemic stroke due to carotid dissection in a boy with Down syndrome
- 13 December 2011
- Published by Springer Nature in Neuroradiology
- Vol. 54 (8) , 901
Erratum to: Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma
- 13 December 2011
- Published by Springer Nature in Neuroradiology
- Vol. 54 (8) , 901
Erratum to: Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma